WAT · News · 20260806N

Acquisition / Partnership / Divestiture

WATERS CORP /DE/ · 2026-08-06 · Importance 71 · Surprise 60

Waters completed the combination with Becton Dickinson’s former Biosciences and Diagnostic Solutions businesses during 2026. The transaction added significant revenue and produced stronger-than-expected growth in the acquired businesses, including through strategic initiatives and new product launches. BD disclosed that the combination generated a $4 billion cash distribution, which was used for share repurchases and debt repayment. Waters continued to identify integration execution and acquisition-related accounting charges as material financial factors.

Key facts

• Empowered Funds LLC lifted its stake in Waters Corporation by 431.0%, owning 7,954 shares after purchasing an additional 6,456 shares source
• A Form 144 SEC filing indicates a proposed sale of 3,626 shares of common stock with an aggregate market value of $1,442,930.44 to be sold via Fidelity Brokerage Services LLC on the NYSE source